Scientists Observe Delayed Progression of Rare Kidney Disease with the Aid of Medication
Researchers are making progress toward developing medications to delay the progression of rare kidney diseases. A study published in the Clinical Journal of the American Society of Nephrology reported a lower decline of estimated glomerular filtration rate (eGFR) among individuals with autosomal dominant polycystic kidney disease (ADPKD) treated with medication, compared to the control group. Glomerular filtration rate (GFR) measures kidney function effectiveness by documenting how well the kidneys are filtering the blood. Researchers hope this type of medication will prevent or delay the need for an individual to go on dialysis or other kidney replacement therapy. The decline of eGFR [...]